Evozyne is a data-driven evolution-based molecular engineering platform for building novel, application-specific proteins with advanced functionality.

Our data-driven technology computationally accelerates what can be achieved through millions of years of evolution. Our approach is vastly more efficient than directed evolution and more comprehensive than physics-based design of proteins.

Our vision

Become the preeminent synthetic biology company by tackling the toughest problems in human health and society through exceptionally advanced proteins.

Our partners

Evozyne was founded by Paragon Biosciences, a top innovator, whose mission is to solve complex human and societal challenges by accelerating development of novel therapies and life science breakthroughs.

Evozyne is well-funded by additional top-tier investors.

Discover next

Meet our team